Breaking News, Financial News

Financial Report: PAREXEL

Revenues up 27% in the quarter

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

PAREXEL 3Q Revenues: $523.5 million (+27%) 3Q Earnings: $29.5 million (+29%) YTD Revenues: $1.5 billion (+27%) YTD Earnings: $65.9 million (+45%) Comments: Clinical Research Services (CRS) revenues were $342.4 million in the quarter, up 30%. PAREXEL Consulting & Medical Communications Services (PCMS) revenues were $50.6 million, up 17%. Perceptive Informatics (PI) revenues were $61.5 million, up 25%....

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters